The current study was conducted to evaluate the antihyperglycemic and antidyslipidemic effects of Withania adpressa aqueous extract (WAAE) in 2 experimental animal models. In streptozotocin-induced diabetic rats, daily oral administration of WAAE at a dose of 20 mg/kg for 15 days significantly reduced fasting blood glucose, improved plasma lipid profile, increased hepatic, muscle glycogen content and enhanced liver histological architecture. In another model of tyloxapol-induced hyperlipidemia, a single oral dose of WAAE at 400 mg/kg significantly reduced plasma concentrations of total cholesterol, triglycerides and LDL-c without affecting HDL-c levels. These results highlight the promising therapeutic potential of Withania adpressa in managing metabolic disorders such as diabetes and dyslipidemia.
31 July 2025 in Tropical Journal of Natural Product Research
Cistanche phelypaea (family: Orobanchaceae) is a medicinal plant traditionally used for its vasorelaxant, diuretic, and sedative properties, highlighting its potential relevance in the management of hypertension. The present study aimed to evaluate the antihypertensive and vasorelaxant effects of Cistanche phelypaea leaves and its impact on angiotensin-converting enzyme 2 (ACE-2). The aqueous leaf extract of Cistanche phelypaea (CPAE) was prepared and its antihypertensive effect (200 mg/kg) was examined using a hypertensive rat model induced by oral administration of L-NAME (60 mg/kg bw), additionally, we assessed its vasorelaxant potential and its impact on the stimulation or inhibition of ACE-2 in isolated rat thoracic aorta. The results indicate that CPAE significantly lowered systolic (p<0.0001), diastolic (p<0.01), and mean arterial pressure (p<0.01) without affecting normotensive rats. The data showed that CPAE mediates its antihypertensive effect via vasodilatory activity. Furthermore, the vasorelaxant capacity of CPAE seems to be mediated through receptor-operated calcium channels (ROCCs). However, CPAE had no effect on ACE-2. In conclusion, the study demonstrates that the aqueous leaf extract of Cistanche phelypaea possesses a significant antihypertensive and vasorelaxant effects, primarily through the inhibition of Ca2+ entry.
According to several studies, antihypertensive drugs have side effects on human health. Therefore, natural products are also being investigated as alternatives to these drugs. For this reason, the present study aimed to examine the vasorelaxant properties of Marrubium multibracteatum aqueous extract (MMAE) on isolated rat aortic rings. The antioxidant potential of MMAE was also evaluated. The vasorelaxant activity of MMAE was assessed on aortic rings precontracted with epinephrine (EP, 10 μM) and potassium chloride (KCl, 80 mM). The antioxidant potential of MMAE was determined using the DPPH (2,2-diphenyl-1-picrylhydrazyl) radical scavenging assay. In addition, the extract underwent phytochemical screening. The results showed that cumulative concentrations of MMAE (0.75 – 1.50 mg/mL) induced a vasorelaxant effect on epinephrine-precontracted aortic rings via the nitric oxide (NO) pathway and inhibited extracellular Ca2+ entry through receptor-operated calcium channels (ROCCs). However, the same concentrations of MMAE exhibited only minimal vasorelaxant effects on KCl (80 mM)-precontracted aortic rings. In contrast, MMAE demonstrated significant antioxidant activity. These findings suggest that MMAE exhibits both potent vasorelaxant and antioxidant properties, likely due to its phytochemical composition, particularly the presence of polyphenols, flavonoids and tannins. Therefore, this extract may represent a promising natural alternative to certain synthetic antihypertensive drugs.
10 October 2026 in European Journal of Pharmacology
Salvia tingitana (S. tingitana) is a medicinal and aromatic plant that belongs to the Lamiaceae family with several medicinal properties. Secondary metabolites, including flavonoids, polyphenols and tannins, were identified through phytochemical analysis of the aerial parts of S. tingitana. In addition, pharmacological investigation revealed this plants’ antihyperglycemic and antihyperlipidemic activities. This study aimed to investigate the antihypertensive and vasorelaxant activities of the aqueous extract of S. tingitana (AEST) in normal and L-NAME-induced hypertensive rats by assessing its effects on heart rate (HR), systolic blood pressure (SBP), mean blood pressure (MBP) and diastolic blood pressure (DBP). The study further investigated the vasorelaxant effect of AEST on isolated rat thoracic aorta and elucidated the underlying mechanisms. As a result, AEST significantly lowered SBP after single and repeated oral administration in normal rats without affecting MBP, DBP and heart rate. Interestingly, after repeated oral AEST administration, arterial blood pressure parameters (SABP, DBP and MBP) significantly decreased in hypertensive rats. The vasorelaxation effect induced by AEST in aortic rings was mediated through numerous pathways involving calcium channels, nitric oxide synthase, muscarinic receptors and inward-rectifying potassium channels. In contrast, the pretreatment with methylene blue, glibenclamide, indomethacin and propranolol did not significantly alter AEST-induced vasorelaxation. The study showed that AEST exhibits a significant antihypertensive effect in L-NAME-rats and exhibits vasorelaxant properties in rat aortic rings via mechanisms involving calcium channels, nitric oxide synthase, muscarinic receptors and inward-rectifying K+ Channels. Interestingly, many further studies on the structure-activity relationship of S. tingitana are needed to explain the mechanisms of action that have been revealed.
Hypertension and dyslipidemia are major causes of cardiovascular disease. Medicinal plants continue to be widely used as therapeutic options for the management of cardiovascular diseases. Santolina africana is a medicinal and aromatic plant of the Asteraceae family, a plant family widely recognized for its beneficial pharmacological effects, particularly in managing cardiovascular diseases. This study aimed to evaluate the antihypertensive, vasorelaxant and antidyslipidemic properties of the aqueous extract of S. africana in animal models of hypertension and dyslipidemia. Normotensive and L-NAME-induced hypertensive rats were orally administered the aqueous extract of S. africana (SAAE) at the doses of 100 and 200 mg/kg and systolic, diastolic and mean blood pressure were measured. The vasorelaxant activity of SAAE and underlying mechanism were evaluated on isolated aortic rings with and without endothelium. Additionally, the antidyslipidemic effect of SAAE (250 and 500 mg/kg) was assessed in Triton WR-1339 induced hyperlipidemic model in rats. Results showed a significant, dose-dependent reduction in blood pressure values in hypertensive rats following SAAE administration. The vasorelaxant effect appeared to be endothelium-dependent and likely mediated by nitric oxide pathway. Furthermore, in Triton WR-1339-induced hyperlipidemic rats, the SAAE significantly lowered plasma levels of total cholesterol, triglycerides and LDL-cholesterol. These findings suggest that S. africana possesses significant antihypertensive, vasorelaxant and antidyslipidemic properties, highlighting its potential as a promising natural therapeutic agent for managing cardiovascular and metabolic disorders.